DAVID MOATAZEDI, CEO & President, Director at Evolus, holds 689.61K shares in Evolus (Ticker: EOLS), holds 83.62K shares in ReShape Lifesciences (Ticker: RSLS), holds 0.00 shares in Biomerica (Ticker: BMRA). Most recently, DAVID MOATAZEDI Sold ― shares of Evolus on Mar 29, 2024 for an estimated value of 86.43K.